ELIAZ THERAPEUTICS
ETI have developed a patented, unique medical device that removes galectin-3 from human blood. The device removes both bound and free galectin-3 from the circulation, offering a new treatment option that is less invasive and has fewer side-effects than other therapies. The single-use apheresis column selectively removes Galectin-3 from the body. It contains a proprietary, highly effective capturing molecule and is built in a format that hospitals already know how to use.
ELIAZ THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Medical Device
Founded:
2015-10-01
Address:
Santa Rosa, California, United States
Country:
United States
Website Url:
http://www.eliaztherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
(707)542-5900
Email Addresses:
[email protected]
Total Funding:
1.7 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Euro Amazon Google Apps For Business
Similar Organizations
Arch Therapeutics
Arch Therapeutics is a medical device company offering an innovative therapeutic approach to stasis and barrier applications.
Sesen Bio, Inc.
Sesen Bio, Inc. is focused on developing innovative protein-based therapeutics to improve human health and treat diseases.
Kintai Therapeutics
Kintai is a biotechnology company that advancing precision therapeutics based on enteric signaling networks in the human body.
Current Advisors List
Current Employees Featured
Founder
Investors List
National Institutes of Health (NIH)
National Institutes of Health (NIH) investment in Grant - Eliaz Therapeutics
Official Site Inspections
http://www.eliaztherapeutics.com Semrush global rank: 8.96 M Semrush visits lastest month: 227
- Host name: sites.framer.app
- IP address: 31.43.161.6
- Location: Makiyivka Ukraine
- Latitude: 48.0478
- Longitude: 37.9258
- Timezone: Europe/Kiev
- Postal: 20754
